DIMS Website

What DIMS Website does

DIMS (Drug Information Management System) is a mobile drug index application for Bangladesh, operated by IT Medicus Solutions and headquartered in Dhaka. The platform provides healthcare professionals — primarily physicians, pharmacists, and nurses — with reference information on 24,000+ brand name drugs and 1,400+ generic drugs available in the Bangladeshi market, covering indications, contraindications, dosage, side effects, precautions, therapeutic class, and FDA pregnancy category. The core technology is a mobile-first application with full offline database access, distributed across Android, iOS, Windows, and a web browser portal (DIMS Plus). A complementary B2B platform, DIMS Gateway, allows pharmaceutical companies to register, curate, and update their drug listings on the platform, with 30+ manufacturers participating including Square Pharmaceuticals, Incepta, GSK Bangladesh, Renata, Apex, and Aristopharma.

The business model combines two revenue streams. Consumer-side revenue comes from tiered premium subscriptions: Gold at 200 BDT for 6 months and Platinum at 300 BDT for 12 months, unlocked via OTP-verified phone number login through the SSLCOMMERZ payment gateway. B2B revenue is generated through pharmaceutical advertising and sponsorships — text ads, banner ads, pop-up ads, and sponsored drug listings — targeting engaged physicians on the platform. The company also offers sister apps including DIMS Rx, Patient Aid, and PDM, indicating a broader digital health product portfolio.

DIMS is positioned as the "premier" drug index of Bangladesh and operates as a privately held, bootstrapped company with 11-50 employees. There is no disclosed external funding, no parent company, and no published revenue figures. Geographic scope is limited to Bangladesh, with no announced international expansion. Operational tooling is conventional: Firebase Analytics for usage telemetry and standard app store distribution channels. The product functions as a clinical reference utility rather than an AI-driven system, and the company has not disclosed any proprietary AI/ML capabilities, patents, or research programs.

Name

DIMS Website

Legal name

IT Medicus Solutions

Website

https://dimsbd.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

DIMS is a mobile drug index platform for Bangladesh, providing physicians and pharmacists offline access to 24,000+ brand drugs and 1,400+ generics via subscription apps. The platform also operates a B2B Gateway serving 30+ pharmaceutical companies with advertising and drug listing services.

Ownership category

akta.pro rank

Product category

Drug Reference Software

NAICS

Web Search Portals, Libraries, Archives, and Other Information Services (519)

SIC

Services-Health Services (8000)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Drug reference app
• Pharmaceutical information system
• Clinical drug database
• Healthcare professional software
• Mobile medical reference

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Premium Subscription - Platinum: Annual subscription providing 12 months access to premium features including disease articles, national guidelines, international guidelines, investigation locator, premium user interface, online bookmark, and daily data updates
2. Premium Subscription - Gold: 6-month subscription with similar premium features including disease articles, guidelines, investigation locator, premium UI, bookmarks, and daily updates
3. Pharmaceutical Advertising & Sponsorship: Pharmaceutical companies can sponsor or advertise products through text ads, banner ads, pop-up ads, and sponsored drug listings to reach engaged physicians

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

DIMS (Drug Information Management System) is a multi-platform clinical drug reference product offered as a mobile app (Android, iOS, Windows) and a web application (DIMS Plus) that gives healthcare professionals access to a database of 24,000+ brand names and 1,400+ generic drugs. It complements this consumer offering with DIMS Gateway, a B2B portal that lets pharmaceutical companies promote brands and engage prescribers, while the app is monetized via freemium subscriptions and in-app advertising.

Product overview

DIMS (Drug Information Management System) is a comprehensive mobile drug index platform for Bangladesh serving healthcare and pharmaceutical professionals. The product suite consists of DIMS Plus (web-based database), the DIMS App (Android/iOS mobile application), and DIMS Gateway (B2B pharmaceutical company management portal). The platform provides information on over 24,000 brand name drugs and 1,400+ generic drugs, available through premium subscription tiers (Gold at 200 BDT/6 months and Platinum at 300 BDT/12 months). Key features include offline drug access, search by brand/generic/condition, therapeutic class browsing, and a pharmaceutical company gateway for database management.

Differentiator

Problem solved

Functional benefit

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature8 records

Partnerships

Eleven partnerships are on record, tiered core.

• Apex Pharma LimitedcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Aristopharma LimitedcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Asiatic Laboratories LtdcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Beacon Pharmaceuticals LtdcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Concord Pharmaceuticals LtdcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Eskayef Pharmaceuticals LtdcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• GlaxoSmithKline BangladeshcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Ibn Sina Pharmaceuticals LtdcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Incepta Pharmaceuticals LtdcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Renata PLCcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.
• Square Pharmaceuticals LtdcoreChannel Partner/ Reseller/ DistributorPharmaceutical company connected to DIMS Gateway for managing and displaying their drug information to doctors on the platform.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• RxList: RxList is a US-based drug reference database offering detailed consumer and professional drug monographs. It is comparable to DIMS as a structured drug information resource and could localize content for South Asian markets.
• 1mg (Tata 1mg): 1mg is an Indian digital health platform combining drug information, online pharmacy, and diagnostic bookings. While primarily a consumer ePharmacy, it includes a physician-facing drug reference that overlaps with DIMS, and Tata-owned 1mg entering Bangladesh would be a high-impact threat.

Direct peers

• Epocrates: Epocrates is a US-based mobile drug reference app for physicians, offering drug information, interaction checking, and clinical tools. It is a direct functional peer to DIMS in terms of product surface, though it operates in a more developed pharma market with significantly higher ARPU.
• Drugs.com: Drugs.com is one of the largest web-based drug information databases, freely accessible to consumers and professionals. It competes with DIMS for physician drug-reference queries in Bangladesh via the web channel and represents a free, well-funded alternative.
• CIMS (Current Index of Medical Specialities) India: CIMS is the leading drug reference for doctors in India with a similar localized brand/generic database and pharma marketing platform. It is the closest country-level peer to DIMS in terms of format, content, and go-to-market model, and represents both a benchmark and a potential expansion template.
• MIMS (Monthly Index of Medical Specialties): MIMS is the dominant drug reference app and print directory for physicians across Asia-Pacific, offering branded drug information, generics, and pharma marketing. It is the most direct global analogue to DIMS, operating in adjacent Asian geographies with the same target user (doctors) and the same dual subscription + pharma marketing model.

Regional players

• Practo: Practo is a leading Indian digital healthcare platform offering doctor discovery, teleconsultation, ePharmacy, and health records. It is a broader-platform peer that could add localized drug reference features and compete with DIMS for physician attention in South Asia.
• Vidal ( Vidal.fr / Vidal Group): Vidal is the leading drug reference database in France, serving physicians and pharmacists with a similar localized drug-information + pharma marketing model. It is comparable to DIMS as a national drug reference incumbent, though operating in a more mature European market.
• PharmEasy: PharmEasy is a major Indian online pharmacy and digital health platform with diagnostic and teleconsultation offerings. While primarily an ePharmacy, its physician-engagement and digital marketing tools overlap with DIMS Gateway's pharma marketing function in the broader South Asian market.

Broad incumbents

• Medscape (WebMD): Medscape is a comprehensive physician platform offering drug reference, clinical news, CME, and decision-support tools. While broader in scope than DIMS, it competes for the same physician mindshare and could localize into Bangladesh, making it the most credible incumbent threat.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/dims.itmedicus

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIMS Website